Gilead Sciences Inc. (GILD): Price and Financial Metrics

GILD POWR Grades

• Value is the dimension where GILD ranks best; there it ranks ahead of 98.84% of US stocks.
• GILD's strongest trending metric is Momentum; it's been moving down over the last 47 weeks.
• GILD ranks lowest in Momentum; there it ranks in the 4th percentile.

GILD Stock Summary

• GILD has a market capitalization of $89,434,227,355 -- more than approximately 97.16% of US stocks.
• With a one year PEG ratio of 1.03, Gilead Sciences Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 5.6% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, Gilead Sciences Inc is reporting a growth rate of 1,688.48%; that's higher than 98.63% of US stocks.
• Stocks that are quantitatively similar to GILD, based on their financial statements, market capitalization, and price volatility, are EW, ADI, AMGN, ATVI, and NTES.
• Visit GILD's SEC page to see the company's official filings. To visit the company's web site, go to www.gilead.com.

GILD Valuation Summary

• GILD's price/sales ratio is 3.4; this is 10.53% lower than that of the median Healthcare stock.
• GILD's price/sales ratio has moved down 24.1 over the prior 243 months.
• Over the past 243 months, GILD's price/sales ratio has gone down 24.1.

Below are key valuation metrics over time for GILD.

GILD Growth Metrics

• The 3 year net cashflow from operations growth rate now stands at -59.15%.
• The 4 year net income to common stockholders growth rate now stands at -71.39%.
• Its year over year net cashflow from operations growth rate is now at 2.25%.

GILD's revenue has moved down $2,463,000,000 over the prior 52 months.

The table below shows GILD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	26,638	9,092	5,162
2021-03-31	25,564	9,342	301
2020-12-31	24,689	8,168	123
2020-09-30	23,147	8,832	1,268
2020-06-30	22,174	9,481	-257
2020-03-31	22,716	9,136	4,962

GILD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GILD has a Quality Grade of B, ranking ahead of 84.92% of graded US stocks.
• GILD's asset turnover comes in at 0.402 -- ranking 114th of 677 Pharmaceutical Products stocks.
• HTBX, PTE, and DRNA are the stocks whose asset turnover ratios are most correlated with GILD.

The table below shows GILD's key quality metrics over time.